Phoebe Tsou
@phoebetsou.bsky.social
Research Assistant @inst-of-liver.bsky.social
2/2
Next steps:
* new immunological associations were highlighted in PBC, warranting further validation studies in bigger cohorts;
* functional studies are needed to investigate these novel biomarkers as suitable immunotherapy targets for PBC treatment.
Next steps:
* new immunological associations were highlighted in PBC, warranting further validation studies in bigger cohorts;
* functional studies are needed to investigate these novel biomarkers as suitable immunotherapy targets for PBC treatment.
January 21, 2025 at 4:13 PM
2/2
Next steps:
* new immunological associations were highlighted in PBC, warranting further validation studies in bigger cohorts;
* functional studies are needed to investigate these novel biomarkers as suitable immunotherapy targets for PBC treatment.
Next steps:
* new immunological associations were highlighted in PBC, warranting further validation studies in bigger cohorts;
* functional studies are needed to investigate these novel biomarkers as suitable immunotherapy targets for PBC treatment.
1/2
Results: increased soluble #HVEM, #interferon #IFN-λ3, #IFN-γ, and #gut barrier permeability significantly differentiated disease stages and UDC response groups.
Results: increased soluble #HVEM, #interferon #IFN-λ3, #IFN-γ, and #gut barrier permeability significantly differentiated disease stages and UDC response groups.
January 21, 2025 at 4:13 PM
1/2
Results: increased soluble #HVEM, #interferon #IFN-λ3, #IFN-γ, and #gut barrier permeability significantly differentiated disease stages and UDC response groups.
Results: increased soluble #HVEM, #interferon #IFN-λ3, #IFN-γ, and #gut barrier permeability significantly differentiated disease stages and UDC response groups.